Medicare Enrolled
Dr. Jeffrey Peller, MD
Rheumatology · Rome, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Peller from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Peller?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Peller
Dr. Jeffrey Peller is a rheumatology specialist in Rome, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Peller performed 68,620 Medicare services across 2,646 unique beneficiaries.
Between the years covered by Open Payments, Dr. Peller received a total of $3,806 from 23 pharmaceutical and/or device companies across 210 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Peller is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in GA
$3,806 industry payments
Medicare Practice Summary
Medicare Utilization ↗68,620
Medicare services
Top 13% in GA for rheumatology
2,646
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,612 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 28,140 | $8 | $15 |
| Denosumab injection (Prolia/Xgeva) | 22,800 | $18 | $50 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
8,985 | $10 | $40 |
| Injection, benralizumab, 1 mg | 1,740 | $132 | $265 |
| Enoxaparin sodium injection, 10 mg A 10 mg injection of enoxaparin sodium, an anticoagulant medication. This procedure involves administering the specified dose of the drug. |
1,038 | $1 | $11 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
677 | $9 | $52 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
620 | $0 | $25 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
463 | $43 | $155 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
388 | $113 | $212 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
362 | $8 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
358 | $77 | $158 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
327 | $7 | $40 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
326 | $3 | $25 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
313 | $34 | $249 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
310 | $10 | $60 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
260 | $6 | $20 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
244 | $5 | $40 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
223 | $25 | $125 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
216 | $86 | $450 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
172 | $48 | $250 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
115 | $14 | $55 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
93 | $18 | $110 |
| Spinal drug pump reprogramming and refill Electronic adjustment of the settings for a spinal drug infusion pump and replenishment of the medication reservoir. |
48 | $66 | $290 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
39 | $59 | $130 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
33 | $4 | $30 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
31 | $4 | $30 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
29 | $3 | $25 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
28 | $6 | $30 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
26 | $14 | $35 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
26 | $2 | $25 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
25 | $29 | $110 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
23 | $16 | $70 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
22 | $26 | $90 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
22 | $18 | $130 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
22 | $8 | $65 |
| Rheumatoid factor level | 21 | $5 | $80 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
20 | $40 | $155 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
18 | $9 | $45 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
17 | $15 | $65 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.3% high complexity
81.3% medium
4.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,806
Total received (2018-2024)
Avg $544/year across 7 years
Bottom 44% in GA for rheumatology
23
Companies
210
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,564 (93.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$242 (6.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$322
2023
$622
2022
$448
2021
$358
2020
$448
2019
$849
2018
$759
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$105
Amgen Inc.
$87
GlaxoSmithKline, LLC.
$37
Novartis Pharmaceuticals Corporation
$21
SOBI, INC
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Radius Health, Inc.
$18
ABBVIE INC.
$16
Top 3 companies account for 71.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$798
Novartis Pharmaceuticals Corporation
$389
PFIZER INC.
$374
AbbVie, Inc.
$370
AbbVie Inc.
$336
Janssen Biotech, Inc.
$291
ABBVIE INC.
$174
Aurinia Pharma U.S., Inc.
$139
GlaxoSmithKline, LLC.
$119
UCB, Inc.
$108
Horizon Therapeutics plc
$102
E.R. Squibb & Sons, L.L.C.
$101
Genentech USA, Inc.
$90
Janssen Scientific Affairs, LLC
$72
AstraZeneca Pharmaceuticals LP
$70
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
Lilly USA, LLC
$63
Radius Health, Inc.
$34
Celgene Corporation
$31
Horizon Pharma plc
$25
SOBI, INC
$19
Sandoz Inc.
$17
SANOFI-AVENTIS U.S. LLC
$16
Top 3 companies account for 41.0% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · Actemra · BENLYSTA · COSENTYX · Cimzia · EVENITY · Enbrel · FORTEO · HUMIRA · Humira · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · OFEV · ORENCIA · Otezla · Prolia · REMICADE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
2
Per 100K population
2.0
County median income
$62,540
Nearest hospital
ADVENTHEALTH REDMOND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Peller is a mixed practice specialist, with above-average Medicare volume (top 13% in GA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Peller experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Peller performed 28,140 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Peller receive payments from pharmaceutical companies?
Yes. Dr. Peller received a total of $3,806 from 23 companies across 210 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Peller's costs compare to other rheumatologists in Rome?
Dr. Peller's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Peller) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Rome
Browse rheumatologists in Rome ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in GA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in GA
Which GA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology